NAGE

Niagen Bioscience INC

-$44.9M

Net Activity

Institutions Holding

144

Popularity Rank

#3645

Avg Weight

0.03%

Total Value

$163.1M

Ownership Trend

144 institutions currently hold NAGE, with 73 net buyers and 96 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

96

Net Buying Institutions

73

Key Holders

View all 144 holding institutions

Quarterly Activity

Recent Activity

+$95.7M

Total Buy Value

$105.2M

Total Sell Value

New buy19
Trim50
Add54
Sold out46

73

Net Buyers

96

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding NIAGEN BIOSCIENCE INC (NAGE)?
Major stakeholders currently include BlackRock, Inc. ($17.1M), SteelPeak Wealth, LLC ($14.9M), Arrowstreet Capital, Limited Partnership ($10.5M). Based on the latest 13F filings, there are a total of 144 tracked investment funds and institutions maintaining positions in NAGE.
What is the overall institutional sentiment toward NAGE recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $44.9M, driven by 73 managers accumulating shares while 96 reduced their exposure.
Which institutions have been selling or reducing their NAGE positions?
In the latest period, 50 funds trimmed their holdings, and 46 managers completely exited their positions. The aggregate reported sell value was $105.2M.
Are there any notable investors adding NAGE to their portfolios?
Yes, buying activity remains notable. 19 institutions opened new positions in {ticker}, and 54 existing holders added to their shares. The total reported buy value for the quarter amounted to $95.7M.

Related Stocks